by Jessica Gwathney | Sep 9, 2024 | Biotechnology, Healthcare, Investing News, Market News, Medical Use, Pharmaceutical
Summit Therapeutics Inc. (NASDAQ: SMMT) is experiencing a significant surge in its stock price, up 63% midday Monday, following the release of groundbreaking data from a key clinical trial. The stock, which closed at $12.27 on Friday, opened at $16 and has been...
